About ArcticDx
ArcticDx is a Healthcare company based in Toronto (Canada) founded in 2005. It operates as a molecular diagnostic tests for multiple diseases are developed. ArcticDx offers products and services including Macula Risk Genetic Testing and In-Office Testing. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its legal entity is MaculaRisk Inc. Similar companies include Everlywell, Viome, Color, Invitae and Counsyl and 4 more; 9 of its 9 listed similar companies have raised funding.
Company details
ArcticDx was founded in 2005 in Toronto, Canada, within the molecular diagnostics sector of healthcare. Genetic tests are developed for conditions such as age-related macular degeneration, cystic fibrosis, and gestational diabetes mellitus. The portfolio encompasses proprietary options like Macula Risk for AMD diagnosis and VitaRisk for supplement selection, alongside Pre-Med for drug management and PreCF for cystic fibrosis screening. Operations focus on personalized medicine applications across these areas.
- Headquarters Toronto, Canada
- SectorsHealthcare
- Email••••••••
- Website arcticdx.com
- Social LinkedIn
- Legal Name Macularisk Inc
Products & Services of ArcticDx
ArcticDx offers a comprehensive portfolio of products and services, including Macula Risk Genetic Testing and In-Office Testing.
Genetic test to assess AMD risks and guide treatments.
On-site service for AMD genetic analysis and recommendations.
Similar companies to ArcticDx
ArcticDx has 9 listed similar companies in our database, 9 of them funded. They include Everlywell, Viome, Color, Invitae and Counsyl, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| color.com | 2013 | Burlingame, United States | $491.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. | |
| newtopia.com | 2008 | New York, United States | $13.1M | – | Health management platform is provided for employers and insurers. | |
| digbihealth.com | 2018 | Mountain View, United States | $5.4M | – | Personalized healthcare is delivered through DNA and gut biome testing. |
Detailed similar companies of ArcticDx
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as ArcticDx (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ArcticDx
ArcticDx was founded in 2005.
ArcticDx is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
ArcticDx was founded in 2005 in Toronto, Canada, within the molecular diagnostics sector of healthcare. Genetic tests are developed for conditions such as age-related macular degeneration, cystic fibrosis, and gestational diabetes mellitus. The portfolio encompasses proprietary options like Macula Risk for AMD diagnosis and VitaRisk for supplement selection, alongside Pre-Med for drug management and PreCF for cystic fibrosis screening. Operations focus on personalized medicine applications across these areas.
ArcticDx's top competitors include Viome, Variant Bio and Newtopia.
ArcticDx offers Macula Risk Genetic Testing and In-Office Testing.
ArcticDx operates through Macularisk Inc.